Gesynta Pharma Receives 27 M For Endometriosis Novel Therapy Drug

Get the Full StorySwedish biotech company Gesynta Pharma AB has secured 27million in a Series B financing round led by Innovestor Life Science in Finland.

Share:

More in Business...

Apple Study To Find Health Uses For iPhones, Watches, AirPods

The Best TSA-Approved Luggage Locks, From Combination To Card-Operated

New York City s New Members-Only Club Balances Approachability And Exclusivity

Why AI Mastery Determines Space Dominance

111 Ways AI Drives Return On Investment